4//SEC Filing
STEINMAN LAWRENCE 4
Accession 0001213900-25-102682
CIK 0001841330other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 5:27 PM ET
Size
5.8 KB
Accession
0001213900-25-102682
Insider Transaction Report
Form 4
STEINMAN LAWRENCE
Director
Transactions
- Award
Stock Option (right to buy)
2025-10-24+242,913→ 242,913 totalExercise: $0.71Exp: 2035-10-23→ Common Stock (242,913 underlying)
Footnotes (1)
- [F1]The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan).
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001132679
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 5:27 PM ET
- Size
- 5.8 KB